C M Bidwell & Associates LTD Vanda Pharmaceuticals Inc. Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $38,528 - $53,387	-2,510 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$15.71 - $21.51 $1,099 - $1,505	-70 Reduced 2.71%	2,510 $54,000
Q1 2021 May 14, 2021	SELL	$13.42 - $20.28 $1,342 - $2,028	-100 Reduced 3.73%	2,580 $39,000
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $26,183 - $37,010	2,680 New	2,680 $35,000

154

43.8M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.